Elsevier

Clinical Microbiology and Infection

Volume 27, Issue 11, November 2021, Pages 1699.e5-1699.e8
Clinical Microbiology and Infection

Research note
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data

https://doi.org/10.1016/j.cmi.2021.06.043Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

Healthcare workers (HCWs) at increased risk of coronavirus disease 2019 (COVID-19) were among the primary targets for vaccine campaigns. We aimed to estimate the protective efficacy of the first three COVID-19 vaccines available in Western Europe.

Methods

We merged two prospective databases that systematically recorded, in our institution: (a) HCWs positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by RT-PCR on nasopharyngeal samples, and (b) HCWs who received at least one dose of COVID-19 vaccine. We excluded HCWs with SARS-CoV-2 infection during the 6 months prior to the study. HCWs were categorized as non-vaccinated if they received no vaccine and until the first injection +13 days, partially vaccinated from the first injection +14 days to the second injection +13 days, and fully vaccinated thereafter.

Results

Of the 8165 HCWs employed in our institution, 360 (4.4%) tested positive for SARS-CoV-2 by RT-PCR during the study period (4th January to 17th May 2021). Incidence was 9.1% (8.2–10.0) in non-vaccinated HCWs, 1.2% (0.7–1.9) after one dose of ChAdOx1 nCoV-19, 1.4% (0.6–2.3) and 0.5% (0.1–1.0) after one and two doses of mRNA BNT162b2, 0.7% (0.1–1.9) and 0% after one and two doses of mRNA-1273 (p < 0.0001). Vaccine effectiveness (Cox model) was estimated at, respectively, 86.2% (76.5–91.0), 38.2% (6.3–59.2), and 49.2% (19.1–68.1) 14 days after the first dose for ChAdOx1 nCoV-19, mRNA-1273, and mRNA-BNT162b2, and 100% (ND) and 94.6% (61.0–99.2) 14 days after the second dose for mRNA-1273 and mRNA-BNT162b2.

Conclusions

In this real-world study, the observed effectiveness of COVID-19 vaccines in HCWs was in line with the efficacy reported in pivotal randomized trials.

Keywords

ChAdOx1 nCoV-19
COVID-19
Effectiveness
Healthcare workers
mRNA-1273
mRNABNT162b2
Vaccine

Cited by (0)